Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Leadership
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Divisions
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Asia Pacific
        • Asia Pacific Leadership
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Foreign Divisions
    • Operational Divisions
    • Wall of Honor
    • Contact Us
  • What We Do
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
  • Resources
    • Recovery Resources
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Drug Enforcement Administration

Daniel J. Kafafian, Acting Special Agent in Charge
New Jersey
@DEANewJerseyDiv
October 23, 2013
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616
For Immediate Release

Manhattan U.S. Attorney Announces Charges Against Owners Of Three Pharmacies, Pharmacists, And Others For Illegal Distribution Of Millions Of Dollars’ Worth Of Oxycodone And Other Painkillers Nine Individuals Allegedly Used New York And New Jersey

NEW YORK - Carl J. Kotowski, Special Agent in Charge of the New Jersey Division of the Drug Enforcement (DEA) and Preet Bharara, the United States Attorney for the Southern District of New York, today announced charges against nine individuals - Paul Wiseberg, Robert Kalaba, Gerald Wiseberg, Stephanie Tomasini, Lana Wiseberg, Emmanuel Antonio, and three pharmacists, Daniel Podell, Howard Hirsh, and Lawrence Zaslow - for their alleged participation in a multimillion-dollar oxycodone distribution ring. The alleged conspiracy involved the distribution of oxycodone and other controlled substances from three pharmacies in New York and New Jersey to customers in Florida who had no legitimate medical need for the drugs.
 
All the defendants were arrested this morning. Kalaba, Podell, Hirsh, and Zaslow will be presented in Manhattan federal court later today. Paul Wiseberg, Gerald Wiseberg, Lana Wiseberg, Tomasini, and Antonio will appear in the Southern District of Florida later today. In addition to the arrests, multiple search warrants were executed and bank accounts restrained in connection with today’s charges.

Manhattan U.S. Attorney Preet Bharara said: “As alleged, these nine defendants, including three licensed pharmacists, created and operated a ring for the illegitimate distribution of prescription painkillers on the East Coast. Prescription drug abuse is our nation’s fastest-growing drug epidemic, and it is especially egregious when, as alleged in this Indictment, health care professionals perpetuate this danger to society.”

DEA Special Agent-in-Charge Carl J. Kotowski said: “Today, DEA and its law enforcement partners delivered another blow to alleged rogue pharmacists who choose to sacrifice their ethics for the almighty dollar. They will now have to deal with the consequences of their alleged decisions.”

According to the Indictment unsealed today in Manhattan federal court:
 
From at least November 2011 up to and including October 2013, Paul Wiseberg, Lana Wiseberg, and Kalaba, none of whom is a medical professional, purchased and operated pharmacies in New York and New (the “Pharmacies”), through which they ordered bulk quantities of highly addictive painkillers such as oxycodone, hydromorphone, and morphine sulfate. Paul Wiseberg and Kalaba then sold and distributed those pain killers via a mail order program at significantly marked-up prices to individuals, mostly in Florida, who had no legitimate medical need for the painkillers.

On average, the Pharmacies would charge from approximately $6 to $9 per pill of oxycodone. A 28-day prescription for oxycodone, which could contain approximately 158 pills, could cost a patient between $948 and $1,400. The same prescription at a retail pharmacy would typically cost less than $200.

Paul Wiseberg, Lana Wiseberg, and Kalaba are not registered with the DEA, and as such, could not themselves obtain oxycodone and other controlled substances from distributors. They relied on Antonio and Podell to obtain hundreds of thousands of oxycodone pills and other controlled substances from distributors. Podell, a licensed pharmacist, signed the necessary forms, and Antonio interacted with the distributors to arrange for the shipments of bulk quantities of painkillers to the Pharmacies.
Gerald Wiseberg and Tomasini recruited pain clinics in Florida that had patients who were willing to pay substantially marked-up prices for the painkillers, and that would thereafter have the prescriptions sent directly to the Pharmacies. At one of the Florida pain clinics, patients were told to mail the prescriptions enclosing money orders and that no insurance or checks would be accepted. They were further instructed not to call or visit the Pharmacies.
 
Podell, Hirsh, and Zaslow, all licensed pharmacists, filled prescriptions for hundreds of thousands of highly addictive painkillers, knowing that the prescriptions were not issued for a legitimate medical purpose. The drugs were then mailed to the customers in Florida. In several instances, prescription drugs were mailed to addresses different from those set forth in the prescriptions. In addition, prescriptions for multiple people were also sometimes sent to the same address.
 
The Indictment also alleges that Paul Wiseberg, Kalaba, Gerald Wiseberg, Tomasini, and Antonio conspired to launder the proceeds of the narcotics conspiracy by both concealing the nature and source of the proceeds, and promoting the distribution of the narcotics.

Mr. Bharara praised the investigative work of the DEA New Jersey Division’s Tactical Diversion Squad, which consists of DEA Agents, Diversion Investigators, and Task Force Officers from the Elizabeth Police Department, Essex County Sheriff’s Office, Toms River Police Department, Clinton Township Police Department, Marlboro Township Police Department, and West Orange Police Department, and the DEA New Jersey Division Diversion Group I. Mr. Bharara also thanked the Internal Revenue Service-Criminal Investigation, participating in the investigation as a member of the El Dorado Task Force, the DEA West Palm Beach Tactical Diversion Squad, the DEA Baltimore Tactical Diversion Squad, and the New Jersey Division of Consumer Affairs, which is part of the New Jersey Office of the Attorney General.

The prosecution is being handled by the Office’s Narcotics Unit. Assistant U.S. Attorneys Carolina A. Fornos and Daniel Tehrani are in charge of the prosecution.

The charges contained in the Indictment are merely accusations, and the defendants are presumed innocent unless and until proven guilty.
  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster